Bifidobacteria have long been recognized as bacteria with probiotic and therapeutic features. The aim of this work is to characterize the Bifidobacterium asteroides BA15 and BA17 strains, isolated from honeybee gut, to evaluate its safety for human use. An in-depth assessment was carried out on safety properties (antibiotic resistance profiling, β-hemolytic, DNase and gelatinase activities and virulence factor presence) and other properties (antimicrobial activity, auto-aggregation, co-aggregation and hydrophobicity). Based on phenotypic and genotypic characterization, both strains satisfied all the safety requirements. More specifically, genome analysis showed the absence of genes encoding for glycopeptide (vanA, vanB, vanC-1, vanC-2, vanD, vanE, vanG), resistance to tetracycline (tetM, tetL and tetO) and virulence genes (asa1, gelE, cylA, esp, hyl).
Bifidobacteria have long been recognized as bacteria with probiotic and therapeutic features. The aim of this work is to characterize the Bifidobacterium asteroides BA15 and BA17 strains, isolated from honeybee gut. An in-depth assessment was carried out on safety properties (antibiotic resistance profiling, β-haemolytic, DNAse and gelatinase activities and virulence factor presence) and other properties (antimicrobial activity, auto-aggregation, co-aggregation and hydrophobicity). Based on phenotypic and genotypic characterization, both strains satisfied all the safety requirements. More specifically, genome analysis showed the absence of genes encoding for glycopeptide (vanA, vanB, vanC-1, vanC-2, vanD, vanE, vanG), resistance to tetracycline (tet-M, tet-L and tetO), and virulence genes (asa1, gelE, cylA, esp, hyl).
The genus Bifidobacterium and Lactobacillus are part of the microbiote of the gastrointestinal tract in human and animal. Certain members of these genera are beneficial to human health and are used as probiotic agents. Camel milk, in addition to its nutritional value, possesses incontestable therapeutic potential against several diseases. These important benefits prompted us to conduct this present research with the aim to firstly, charaterize tow indigenous strains and to screen their probiotic attributes and, secondly, evaluate their viability in camel milk during cold storage. Phenotypic and genotypic identification showed that strain Lb49 belongs to Lactbacillus paracasei. subsp. Paracasei, and the strain Bif21 belongs to Bifidobacterium asteroides. The study showed the safety aspect of the two identified strains, high resistance towards bile (SR> 71%), lysozyme (SR> 81%), low to moderate auto-aggregation (10.9-44.4%) and hydrophobicity (23.4-41.9) as well as antimicrobial activity against the tested pathogens with the highest scores recorded by the strain Lb49. When exposed to low pH conditions, only the strain Lb49 exhibited high tolerance with SR> 77%. Regarding the strain’s viability in camel milk, they maintained an excellent viability (93.5-100.5 %) after 15 days storage at 4° C. The characteristics demonstrated by Lb49 enable it to be used as a potential probiotic as well as Bif21 strain, as far as protection is provided for their survival by filling their intolerance to acidic stress using an adequate technique. Moreover, camel milk guaranteed excellent viability for the studied strains thanks to its physicochemical composition, acting as a good medium for nutrition and transport of probiotics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.